Richard Willock - Definigen

Richard Willock

Chief Business Officer

Richard’s research background is in Genomics and Molecular Genetics, he graduated from Sussex University and then worked for 5 years as a Research Scientist at GlaxoSmithKline, where he focussed on the development of genetic biomarker strategies for personalised medicine. He has over 15 years of experience in global business development roles at companies such as Packard Bioscience and PerkinElmer, where he was responsible for sales and commercial strategy in the automation and assay technology sectors. He spent nine years at Asterand Bioscience, a human-tissue based research services provider, where he was responsible for transformative revenue growth across Europe and USA. As an Executive Director of DefiniGEN, he oversees the creation and execution of the company’s global business development strategy.

Richard Willock, Chief Business Officer at DefiniGEN